ORAL ANTICOAGULANT TREATMENT IN A MEDICAL-CARE DISTRICT - A DESCRIPTIVE STUDY

被引:6
作者
JANSSON, JH
WESTMAN, G
BOMAN, K
NILSSON, T
NORBERG, B
机构
[1] SKELLEFTEA HOSP,DEPT INTERNAL MED,SKELLEFTEA,SWEDEN
[2] UMEA UNIV HOSP,DEPT FAMILY MED,S-90185 UMEA,SWEDEN
[3] UMEA UNIV HOSP,DEPT CLIN CHEM,S-90185 UMEA,SWEDEN
[4] UMEA UNIV HOSP,DEPT INTERNAL MED,S-90185 UMEA,SWEDEN
关键词
ANTICOAGULATION; WARFARIN; COUMARIN; BLEEDING COMPLICATIONS; THROMBOEMBOLISM; PRIMARY HEALTH CARE; QUALITY ASSURANCE;
D O I
10.3109/02813439508996774
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective - To describe how oral anticoagulant therapy is performed in a defined catchment area in order to improve the quality of care. Design - Two study periods of 8 weeks were compared with reference to monitoring sites, i.e. hospital departments and primary health care centres. Setting - The health care district of Umea in northern Sweden, with 125 300 inhabitants. Participants - Patients on oral anticoagulant therapy at the department of Internal Medicine, Umea University Hospital, in 1987 (n=243) were compared with all patients treated in 1990 at health centres (n=175) and at the department of Internal Medicine (n=290) in the Umea district. Main outcome measures - The prevalence of treatment failures and complications was calculated per patient year, as well as the relative frequencies of patients within treatment recommendations. Results - 80-83% of the patients were within treatment recommendations. Treatment failures were 3.6% of hospital patients, and 2.6% of primary care patients. Corresponding figures for bleeding complications were 8.9% and 5.1%, respectively. The differences are partly explained by differences in the studied groups, e.g. age, indications for treatment, and concomitant diseases.
引用
收藏
页码:268 / 274
页数:7
相关论文
共 19 条
[1]  
ANDERSSON P, 1981, OPMEAR, V26, P131
[2]   THERAPEUTIC CONTROL OF ANTICOAGULANT TREATMENT [J].
DUXBURY, BM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6317) :702-704
[3]  
HARRIES AD, 1981, LANCET, V1, P1320
[4]   ANTICOAGULANT-THERAPY IN CEREBROVASCULAR-DISEASE - REVIEW AND META-ANALYSIS [J].
JONAS, S .
STROKE, 1988, 19 (08) :1043-1048
[5]  
KUMAR S, 1989, THROMB HAEMOSTASIS, V62, P729
[6]   BLEEDING COMPLICATIONS TO ORAL ANTICOAGULANT-THERAPY - MULTIVARIATE-ANALYSIS OF 1010 TREATMENT YEARS IN 551 OUTPATIENTS [J].
LAUNBJERG, J ;
EGEBLAD, H ;
HEAF, J ;
NIELSEN, NH ;
FUGLEHOLM, AM ;
LADEFOGED, K .
JOURNAL OF INTERNAL MEDICINE, 1991, 229 (04) :351-355
[7]   RISK OF HEMORRHAGE ASSOCIATED WITH LONG-TERM ANTICOAGULANT-THERAPY [J].
LEVINE, MN ;
RASKOB, G ;
HIRSH, J .
DRUGS, 1985, 30 (05) :444-460
[8]   HEMORRHAGIC COMPLICATIONS OF LONG-TERM ANTICOAGULANT-THERAPY [J].
LEVINE, MN ;
RASKOB, G ;
HIRSH, J .
CHEST, 1989, 95 (02) :S26-S36
[9]  
LUNDSTROM T, 1989, J INT MED, V224, P137
[10]  
MCINNES GT, 1981, 4TH P ANN WAMI M POL, P306